Successful treatment of refractory adult onset Still's disease with rituximab.
Ahmadi-Simab
K
K
Lamprecht
P
P
Jankowiak
C
C
Gross
W L
WL
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D001402:B-Lymphocytes / Q000276:immunology; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007375:Interleukin-1 / Q000037:antagonists & inhibitors; D008212:Lymphocyte Depletion; D000069283:Rituximab; D016706:Still's Disease, Adult-Onset / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D007375:Interleukin-1; D000069283:Rituximab